People

Zoran Zdraveski

Zoran Zdraveski chairs gMendel’s board. A biochemistry PhD with chemistry and law qualifications, he is a biopharmaceutical legal and intellectual-property executive at TScan Therapeutics, with earlier Magenta and Epizyme experience. The company announced his board appointment in May2023; its January2023 presentation records an earlier strategic-adviser capacity.